Page 2 - Nautilus Platform News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Vanguard Capital Wealth Advisors increased its holdings in Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Free Report) by 228.3% during the 1st quarter, Holdings Channel reports. The firm owned 75,500 shares of the company’s stock after buying an additional 52,500 shares during the period. Vanguard Capital Wealth Advisors’ holdings in Nautilus Biotechnology were worth $209,000 at the […]

Clarius Group LLC lifted its position in shares of Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) by 1.8% during the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 597,972 shares of the company’s stock after purchasing an additional 10,667 shares […]

Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) shares reached a new 52-week high on Tuesday . The company traded as high as $4.08 and last traded at $4.05, with a volume of 23382 shares. The stock had previously closed at $3.98. Nautilus Biotechnology Stock Performance The stock’s 50 day moving average is $2.77 and its […]

Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating) was the recipient of a significant increase in short interest in the month of May. As of May 31st, there was short interest totalling 591,700 shares, an increase of 29.7% from the May 15th total of 456,200 shares. Based on an average daily volume of 98,100 shares, the […]

Nautilus Biotechnology, Inc. (NASDAQ:NAUT – Get Rating)’s share price was up 5.6% during mid-day trading on Monday . The stock traded as high as $2.45 and last traded at $2.44. Approximately 62,672 shares changed hands during trading, a decline of 42% from the average daily volume of 107,658 shares. The stock had previously closed at […]